Virtual Cross-Linking of the Active Nemorubicin Metabolite PNU-159682 to Double-Stranded DNA.
Matteo ScalabrinLuigi QuintieriManlio PalumboFederico Riccardi SirtoriBarbara GattoPublished in: Chemical research in toxicology (2017)
The DNA alkylating mechanism of PNU-159682 (PNU), a highly potent metabolite of the anthracycline nemorubicin, was investigated by gel-electrophoretic, HPLC-UV, and micro-HPLC/mass spectrometry (MS) measurements. PNU quickly reacted with double-stranded oligonucleotides, but not with single-stranded sequences, to form covalent adducts which were detectable by denaturing polyacrylamide gel electrophoresis (DPAGE). Ion-pair reverse-phase HPLC-UV analysis on CG rich duplex sequences having a 5'-CCCGGG-3' central core showed the formation of two types of adducts with PNU, which were stable and could be characterized by micro-HPLC/MS. The first type contained one alkylated species (and possibly one reversibly bound species), and the second contained two alkylated species per duplex DNA. The covalent adducts were found to produce effective bridging of DNA complementary strands through the formation of virtual cross-links reminiscent of those produced by classical anthracyclines in the presence of formaldehyde. Furthermore, the absence of reactivity of PNU with CG-rich sequence containing a TA core (CGTACG), and the minor reactivity between PNU and CGC sequences (TACGCG·CGCGTA) pointed out the importance of guanine sequence context in modulating DNA alkylation.
Keyphrases
- ms ms
- mass spectrometry
- circulating tumor
- nucleic acid
- cell free
- simultaneous determination
- single molecule
- high performance liquid chromatography
- liquid chromatography
- multiple sclerosis
- genetic diversity
- tandem mass spectrometry
- binding protein
- high resolution
- gas chromatography
- circulating tumor cells
- capillary electrophoresis
- room temperature
- hyaluronic acid
- wound healing